These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillers. Schelke LW; Velthuis P; Kadouch J; Swift A J Am Acad Dermatol; 2023 Jan; 88(1):79-85. PubMed ID: 31325548 [TBL] [Abstract][Full Text] [Related]
5. [Vascular occlusion after filler injection with hyaluronic acid]. Zidane M; Eisert L; Nast A Hautarzt; 2021 Apr; 72(4):329-331. PubMed ID: 32936317 [No Abstract] [Full Text] [Related]
6. Delayed Adverse Subcutaneous Reaction to a New Family of Hyaluronic Acid Dermal Fillers With Clinical, Ultrasound, and Histologic Correlation. Pérez-Pérez L; García-Gavín J; Wortsman X; Santos-Briz Á Dermatol Surg; 2017 Apr; 43(4):605-608. PubMed ID: 27748693 [No Abstract] [Full Text] [Related]
8. The Utility of Color Doppler Ultrasound to Explore Vascular Complications After Filler Injection. Kwon HJ; Kim BJ; Ko EJ; Choi SY Dermatol Surg; 2017 Dec; 43(12):1508-1510. PubMed ID: 28445201 [No Abstract] [Full Text] [Related]
9. Bone Resorption in Mentum Induced by Unexpected Soft-Tissue Filler. Guo X; Song G; Zong X; Jin X Aesthet Surg J; 2018 Sep; 38(10):NP147-NP149. PubMed ID: 30084888 [No Abstract] [Full Text] [Related]
10. Ophthalmic Artery Occlusion After Cosmetic Facial Filler Injections. Shi H; Liang LL; Cui ZH JAMA Ophthalmol; 2018 Jun; 136(6):e180764. PubMed ID: 29902317 [No Abstract] [Full Text] [Related]
12. Five-Year Postmarket Safety Experience With the Optimal Balance Technology Range of Hyaluronic Acid Fillers. Jones DH; Bank D; Jacobsson J; Koltowska-Häggström M; Wong C Dermatol Surg; 2020 Jan; 46(1):145-147. PubMed ID: 30789520 [No Abstract] [Full Text] [Related]
13. Delayed Inflammatory Reaction to VYC-25L Hyaluronic Acid Filler in a Patient Without a Reaction to VYC-20L. Burleigh A; Rivers JK; Diao D Dermatol Surg; 2021 May; 47(5):745-746. PubMed ID: 32826603 [No Abstract] [Full Text] [Related]
14. Prevention of hyaluronic acid filler-induced blindness. Lee W Dermatol Ther; 2020 Jul; 33(4):e13657. PubMed ID: 32445274 [No Abstract] [Full Text] [Related]
15. Orbital and Ocular Ischemic Syndrome With Blindness After Facial Filler Injection. Ramesh S; Fiaschetti D; Goldberg RA Ophthalmic Plast Reconstr Surg; 2018; 34(4):e108-e110. PubMed ID: 29547471 [TBL] [Abstract][Full Text] [Related]
16. Dermal Filler-Induced Vascular Occlusion Successfully Treated With Tadalafil, Hyaluronidase, and Aspirin. Chuchvara N; Alamgir M; John AM; Rao B Dermatol Surg; 2021 Aug; 47(8):1160-1162. PubMed ID: 33867474 [No Abstract] [Full Text] [Related]
17. Rosacea-like acute reaction after hyaluronic acid dermal filler. Valenti M; Guanziroli E; Mancini LL; Costanzo A Ital J Dermatol Venerol; 2021 Dec; 156(Suppl. 1 to No. 6):76-77. PubMed ID: 31804049 [No Abstract] [Full Text] [Related]
18. Hyperbaric Oxygen Therapy in Hyaluronic Acid Filler-Induced Dermal Ischemia. Kruize RGF; Teguh DN; van Hulst RA Dermatol Surg; 2020 Dec; 46(12):1755-1757. PubMed ID: 31490298 [No Abstract] [Full Text] [Related]
19. Efficacy of combination light-emitting diode (635 and 830 nm) therapy in treating local injection-site reactions after filler. Yoo KH; Yeo IK; Hyun MY; Hong CK; Kim BJ Clin Exp Dermatol; 2015 Apr; 40(3):333-5. PubMed ID: 25266806 [No Abstract] [Full Text] [Related]
20. Unraveling the Intricacies of Early Complications in Hyaluronic Acid Filler Procedures: A Scholarly Critique and Analysis. Rahman E; Rao P; Philipp-Dormston WG; Webb WR; Carruthers JD; Carruthers A Aesthet Surg J; 2023 Dec; 44(1):NP127-NP129. PubMed ID: 37706360 [No Abstract] [Full Text] [Related] [Next] [New Search]